410 related articles for article (PubMed ID: 26250537)
1. Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer.
Hong X; Cui B; Wang M; Yang Z; Wang L; Xu Q
Tohoku J Exp Med; 2015 Aug; 236(4):297-304. PubMed ID: 26250537
[TBL] [Abstract][Full Text] [Related]
2. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
3. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Wang C; Jin S; Xu S; Cao S
Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
[TBL] [Abstract][Full Text] [Related]
4. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
[TBL] [Abstract][Full Text] [Related]
5. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
[TBL] [Abstract][Full Text] [Related]
6. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
[TBL] [Abstract][Full Text] [Related]
8. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
[TBL] [Abstract][Full Text] [Related]
9. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study.
Furuncuoğlu Y; Tulgar S; Dogan AN; Cakar S; Tulgar YK; Cakiroglu B
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1300-6. PubMed ID: 27097950
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
Wang X; Jiang R; Li K
Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.
Käsmann L; Bolm L; Schild SE; Janssen S; Rades D
Lung; 2017 Apr; 195(2):217-224. PubMed ID: 28154994
[TBL] [Abstract][Full Text] [Related]
12. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer.
Zhang X; Ren H; Tian J; Yang C; Luo H
Heliyon; 2024 Jan; 10(1):e23830. PubMed ID: 38192754
[TBL] [Abstract][Full Text] [Related]
14. Systemic Immune-inflammation Index Predicts Survival of Patients After Curative Resection for Non-small Cell Lung Cancer.
Tomita M; Ayabe T; Maeda R; Nakamura K
In Vivo; 2018; 32(3):663-667. PubMed ID: 29695576
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancer.
Drpa G; Sutic M; Baranasic J; Jakopovic M; Samarzija M; Kukulj S; Knezevic J
Radiol Oncol; 2020 Sep; 54(4):437-446. PubMed ID: 32960780
[TBL] [Abstract][Full Text] [Related]
16. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M
Thorac Cancer; 2020 Jun; 11(6):1578-1586. PubMed ID: 32286017
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.
Suzuki R; Lin SH; Wei X; Allen PK; Welsh JW; Byers LA; Komaki R
Radiother Oncol; 2018 Mar; 126(3):499-505. PubMed ID: 29398150
[TBL] [Abstract][Full Text] [Related]
18. The Addition of Peripheral Blood Inflammatory Indexes to Nomogram Improves the Predictive Accuracy of Survival in Limited-Stage Small Cell Lung Cancer Patients.
Qi J; Zhang J; Ge X; Wang X; Xu L; Liu N; Zhao L; Wang P
Front Oncol; 2021; 11():713014. PubMed ID: 34692490
[TBL] [Abstract][Full Text] [Related]
19. Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis.
Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
Syst Rev; 2021 Jan; 10(1):40. PubMed ID: 33509254
[TBL] [Abstract][Full Text] [Related]
20. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
